IPOPLUS

949.65

-19.45 -2.01%

17 Jun 2026

NSE Listed

Fortis Healthcare Limited (FORTIS)

Volume: 9,34,183Avg Vol 1W: 19,36,208.4Avg Vol 1M: 13,99,651.552W Range:742.21,104.3
₹949.65 2.01%
Key Ratios
Updated 4h ago
Market Cap₹74,771 Cr
Current Price₹949.65
Previous Close₹969.1
High / Low (52w)₹1,104.3 / ₹742.2
Volume9,34,183
Avg Vol (1W)19,36,208.4
Avg Vol (1M)13,99,651.5
Stock P/E281.35
Book Value₹131.07
Dividend Yield0.1%
ROE10.5%
ROA6.7%
Revenue (TTM)₹7,850 Cr
Revenue Growth12.9%
Profit Margin11.4%
Total Debt₹2,086 Cr
Shares Outstanding75 Cr
Face Value₹10
EPS (TTM)₹3.52
P/B7.56
Debt / Equity0.35
50 DMA₹931.71
200 DMA₹927.91
Day change-2.01%
Price Chart
949.65 24.71% · 1Y
10987475.9Cr
2025-06-17
2026-06-12

20-day avg volume: 14.0L shares

Pros
  • Company is almost debt-free.
  • Revenue grew 15% YoY.
Cons
  • Stock trades at a high P/E of 281.
Quarterly Results
MetricJun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue₹1,859 Cr₹1,988 Cr₹1,928 Cr₹2,007 Cr₹2,167 Cr₹2,331 Cr₹2,265 Cr₹2,365 Cr
EBITDA₹265 Cr₹353 Cr₹299 Cr₹353 Cr₹405 Cr₹473 Cr₹394 Cr₹415 Cr
Net Profit₹166 Cr₹176 Cr₹248 Cr₹184 Cr₹260 Cr₹322 Cr₹194 Cr₹266 Cr
EPS
Profit & Loss (Annual)
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Revenue₹4,685 Cr₹4,077 Cr₹5,745 Cr₹6,359 Cr₹6,931 Cr₹7,850 Cr
EBITDA₹370 Cr₹160 Cr₹795 Cr₹847 Cr₹963 Cr₹1,269 Cr
Net Profit₹58 Cr₹-110 Cr₹555 Cr₹589 Cr₹599 Cr₹774 Cr
EPS
Balance Sheet
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Total Assets₹11,348 Cr₹11,155 Cr₹11,885 Cr₹12,434 Cr₹13,289 Cr₹13,692 Cr
Total Liabilities₹4,142 Cr₹4,437 Cr₹4,876 Cr₹4,333 Cr₹4,733 Cr₹4,522 Cr
Equity₹7,206 Cr₹6,718 Cr₹7,008 Cr₹8,100 Cr₹8,556 Cr₹9,169 Cr
Total Debt₹954 Cr₹968 Cr₹779 Cr₹572 Cr₹741 Cr₹2,086 Cr
Cash Flow
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating₹511 Cr₹438 Cr₹1,077 Cr₹1,096 Cr₹1,322 Cr₹1,534 Cr
Investing₹60 Cr₹-135 Cr₹-514 Cr₹-374 Cr₹-886 Cr₹-779 Cr
Financing₹-862 Cr₹-143 Cr₹-517 Cr₹-471 Cr₹-86 Cr₹-714 Cr
Free Cash Flow₹511 Cr₹438 Cr₹1,077 Cr₹1,096 Cr₹1,322 Cr₹1,534 Cr

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search